Patel Chem FY26 Net Profit Rises 19% to ₹1,255 Lakh
Patel Chem Specialities Limited reported a 19% increase in FY26 net profit to ₹1,255.22 lakh, supported by a 30.6% rise in revenue from operations to ₹13,726.33 lakh. Total revenue for the year reached ₹13,908.19 lakh, while total expenses were managed at ₹12,209.91 lakh. The board approved the audited financial results, re-appointed statutory and internal auditors for FY27, and confirmed no deviation in IPO fund utilization.
*this image is generated using AI for illustrative purposes only.
Patel Chem Specialities Limited announced its audited financial results for the year ended March 31, 2026, reporting a significant rise in profitability and operational revenue. The company's net profit for the fiscal year stood at ₹1,255.22 lakh, an increase of 19% compared to ₹1,056.52 lakh in the previous year. This growth was driven by a robust performance in revenue from operations, which climbed to ₹13,726.33 lakh from ₹10,508.78 lakh in FY25.
Financial Performance
The total revenue for FY26 reached ₹13,908.19 lakh, up from ₹10,555.18 lakh in the corresponding period last year. While the cost of raw materials consumed rose to ₹10,177.42 lakh, the company managed its total expenses effectively at ₹12,209.91 lakh. Profit before tax for the year was recorded at ₹1,698.28 lakh, compared to ₹1,409.53 lakh in the prior year. The basic and diluted earnings per share (EPS) improved to ₹6.63 from ₹5.91 in the previous year.
Operational Metrics
The board reviewed and approved the annual audited financial statements alongside the draft auditor's report. The statutory auditors, M/s Parikh Shah & Associates, issued an unmodified opinion on the audited financial results. The company also noted that it does not have more than one reportable segment in terms of AS-17, making segment-wise reporting inapplicable.
Board Decisions
In addition to the financial results, the Board of Directors approved the re-appointment of several auditors for FY 2026-2027. M/s Bimal Shah Associates were re-appointed as Internal Auditors, M/s RTBR & Associates as Secretarial Auditors, and M/s BRS & Associates as Cost Auditors. The board also reviewed related party transactions for the half-year ended March 31, 2026, and took note of the statement of utilization of funds raised through the IPO.
Financial Results Summary
| Particulars | FY26 (₹ in Lakhs) | FY25 (₹ in Lakhs) |
|---|---|---|
| Revenue from Operations | 13,726.33 | 10,508.78 |
| Total Revenue | 13,908.19 | 10,555.18 |
| Total Expenses | 12,209.91 | 9,145.65 |
| Profit Before Tax | 1,698.28 | 1,409.53 |
| Net Profit | 1,255.22 | 1,056.52 |
| EPS (Basic & Diluted) | 6.63 | 5.91 |
The company confirmed that there was no deviation or variation in the use of proceeds from the objects stated in the prospectus for the half-year ended March 31, 2026. The total funds raised through the IPO amounted to ₹5,880 lakhs, with a significant portion allocated to capital expenditure and general corporate purposes.
Historical Stock Returns for Patel Chem Specialities
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.29% | +20.00% | -0.02% | +5.23% | -14.84% | -14.84% |
How will Patel Chem Specialities deploy the remaining IPO proceeds allocated to capital expenditure, and what revenue impact is expected from these investments in FY27?
Given the sharp rise in raw material costs to ₹10,177.42 lakh, what strategies is the company considering to hedge against commodity price volatility and protect margins going forward?
With revenue growing ~31% year-over-year, which specific product segments or geographies are driving this growth, and is this trajectory sustainable in FY27?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
